• By The Financial District

U.S. Firm Unveils New Antiviral Solutions That Battle COVID-19

Microban International, a global leader in antimicrobial solutions, odor control, and residual sanitization and disinfection, has unveiled new antiviral technologies that reduce viral loading on products and surfaces, Deutsche Presse-Agentur (dpa) reported.

Photo Insert: The Microban line of antimicrobial solutions

A subsidiary of Barr Brands Int’l (BBI) of the US, Microban has long been a trusted partner in a wide range of sectors, from consumer and healthcare to industrial and construction. Microban technology can be incorporated into various materials during manufacturing to protect the product from microbes.

Recent data demonstrate that new antiviral technologies from Microban conform to both ISO 18184 – which assesses the antiviral performance of treated textile products, such as woven and knitted fabrics, fibers, yarns, and braids – and ISO 21702, which measures activity in treated plastics and other non-porous surfaces.

Thorough testing was performed to evaluate the efficacy of each product type against many viruses, including bacteriophage Phi6, an important surrogate virus for SARS-CoV-2. The results showed that articles treated with these technologies can now benefit from reduced viral loading* by up to 99 %.

All the news: Business man in suit and tie smiling and reading a newspaper near the financial district.

Antiviral technologies from Microban inhibit the viruses’ ability to remain viable on surfaces. The modes of action vary, disrupting the structure of either the outer protein coat – to prevent viruses from recognizing or binding to host cells – or nucleic acid payload, to prevent viral replication.

This gives manufacturers a valuable product feature and provides consumers with added peace of mind.

Business: Business men in suite and tie in a work meeting in the office located in the financial district.

Michael Ruby, President of Microban International, explained: “We are excited with the latest results confirming the antiviral activity of our new technologies. Assessing antiviral efficacy in treated products to a standard that meets the complex regulatory landscape is an arduous process, but we have been confident throughout that our innovative solutions conformed to the rigorous ISO standards. Our world-class research team and global in-house regulatory department worked diligently to ensure that the technology is recognized as effective and compliant across various markets, to support partners with their claims, and give customers even greater confidence in products protected with Microban antiviral technology.”

WEEKLY FEATURE : MVP Group Keeps Lights On During Pandemic

Optimize asset flow management and real-time inventory visibility with RFID tracking devices and custom cloud solutions.
Sweetmat disinfection mat